Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Glaxo Wellcome discloses prodrugs of known 5-HT1-like agonist

April 3, 1997

Abbott reveals compounds for controlling synaptic transmission

April 3, 1997

New epilepsy option approved in the U.S.

April 2, 1997

Guilford's neuroimmunophilin ligands covered by U.S. patent

April 2, 1997

Cationized AVP fragment for learning and memory disorders from Yakult

April 2, 1997

New device for carpal tunnel syndrome

April 2, 1997

MS&D prepares antimigraine pyrrolo-pyridine derivatives

April 2, 1997

Cytogen's Quadramet approved by FDA

April 1, 1997

Syrup formulation of Zofran available in the U.K.

April 1, 1997

U.K. introduction for intranasal sumatriptan

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...